NIH: Drug Discovery Grant for Nervous System Disorders (R21)

Opportunity ID: 43750

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-07-049
Funding Opportunity Title: Drug Discovery for Nervous System Disorders (R21)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 05, 2008
Last Updated Date:
Original Closing Date for Applications: – Multiple Receipt Dates – See Link to Full Announcement for details.
Current Closing Date for Applications: Jan 07, 2010 Multiple Receipt Dates – See Link to Full Announcement for details.
Archive Date: Feb 07, 2010
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
State governments
Private institutions of higher education
Small businesses
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
City or township governments
Additional Information on Eligibility: Foreign institutions are eligible to apply.

Additional Information

Agency Name: National Institutes of Health
Description: -Purpose. This funding opportunity announcement (FOA) solicits Exploratory/Developmental (R21) grant applications from applicant organizations directed toward the discovery, development, and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. -Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with an FOA of identical scientific scope, PAR-07-048, that solicits applications under the R01 mechanism and which will be issued at a later date. -Funds Available and Anticipated Number of Awards. There is no set-aside funding for this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-07-049.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Archive Date has been updated due to Expiration/Closing Date change.
Dec 05, 2008

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-07-049
Funding Opportunity Title: Drug Discovery for Nervous System Disorders (R21)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 05, 2008
Last Updated Date:
Original Closing Date for Applications: – Multiple Receipt Dates – See Link to Full Announcement for details.
Current Closing Date for Applications: Jan 07, 2010 Multiple Receipt Dates – See Link to Full Announcement for details.
Archive Date: Feb 07, 2010
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Native American tribal governments (Federally recognized)
State governments
Private institutions of higher education
Small businesses
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
City or township governments
Additional Information on Eligibility: Foreign institutions are eligible to apply.

Additional Information

Agency Name: National Institutes of Health
Description: -Purpose. This funding opportunity announcement (FOA) solicits Exploratory/Developmental (R21) grant applications from applicant organizations directed toward the discovery, development, and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. -Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with an FOA of identical scientific scope, PAR-07-048, that solicits applications under the R01 mechanism and which will be issued at a later date. -Funds Available and Anticipated Number of Awards. There is no set-aside funding for this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-07-049.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-07-049
Funding Opportunity Title: Drug Discovery for Nervous System Disorders (R21)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 05, 2008
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: – Multiple Receipt Dates – See Link to Full Announcement for details.
Archive Date: Dec 16, 2009
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Independent school districts
County governments
State governments
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Native American tribal governments (Federally recognized)
Small businesses
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Foreign institutions are eligible to apply.

Additional Information

Agency Name: National Institutes of Health
Description: -Purpose. This funding opportunity announcement (FOA) solicits Exploratory/Developmental (R21) grant applications from applicant organizations directed toward the discovery, development, and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. -Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with an FOA of identical scientific scope, PAR-07-048, that solicits applications under the R01 mechanism and which will be issued at a later date. -Funds Available and Anticipated Number of Awards. There is no set-aside funding for this FOA. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-07-049.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
ADOBE-FORMS-A Adobe-Forms-A PKG00009098 Dec 05, 2008 Jan 07, 2010 View

Package 1

Mandatory forms

43750 RR_SF424-1.1.pdf

43750 RR_KeyPersonExpanded-1.1.pdf

43750 RR_OtherProjectInfo-1.1.pdf

43750 RR_PerformanceSite-1.1.pdf

43750 PHS398_CoverPageSupplement-1.1.pdf

43750 PHS398_ResearchPlan-1.1.pdf

43750 PHS398_Checklist-1.1.pdf

Optional forms

43750 PHS398_CoverLetter-1.1.pdf

43750 PHS398_ModularBudget-1.1.pdf

43750 RR_Budget-1.1.pdf

43750 RR_SubawardBudget-1.2.pdf


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *